Vr Adviser, LLC Viridian Therapeutics, Inc.\De Transaction History
Vr Adviser, LLC
- $1.17 Billion
- Q1 2024
A detailed history of Vr Adviser, LLC transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, Vr Adviser, LLC holds 3,882,671 shares of VRDN stock, worth $47.6 Million. This represents 5.84% of its overall portfolio holdings.
Number of Shares
3,882,671
Previous 3,882,623
-0.0%
Holding current value
$47.6 Million
Previous $84.6 Million
19.6%
% of portfolio
5.84%
Previous 10.39%
Shares
10 transactions
Others Institutions Holding VRDN
# of Institutions
143Shares Held
62.1MCall Options Held
160KPut Options Held
354K-
Paradigm Biocapital Advisors LP New York, NY5.03MShares$61.6 Million3.3% of portfolio
-
State Street Corp Boston, MA4.49MShares$55 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.81MShares$46.7 Million0.0% of portfolio
-
Perceptive Advisors LLC New York, NY3.66MShares$44.8 Million1.34% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.46MShares$42.3 Million2.0% of portfolio
About Viridian Therapeutics, Inc.\DE
- Ticker VRDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,888,900
- Market Cap $489M
- Description
- Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...